U.S. Office-based Labs Market Size, Share & Trends Analysis Report By Modality (Hybrid Labs, Multi-specialty Labs), By Service (Cardiac, Endovascular Intervention, Venous, Interventional Radiology), By Specialist, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                      1.1. Market Segmentation
                      1.2. Market Definitions
                          1.2.1. Modality
                          1.2.2. Service
                          1.2.3. Specialist
                      1.3. Estimates and Forecast Timeline
                      1.4. Research Methodology
                          1.4.1. Information procurement
                          1.4.2. Purchased Database
                          1.4.3. GVR's Internal Database
                          1.4.4. Secondary Sources
                          1.4.5. Primary Research
                          1.4.6. Details of Primary Research
                      1.5. Information or Data Analysis
                          1.5.1. Data Analysis Models
                      1.6. Market Formulation & Validation
                          1.6.1. Commodity Flow Analysis
                      1.7. List of Secondary Sources
                      1.8. List of Abbreviations
                      1.9. Research Objectives
Chapter 2. Executive Summary
                      2.1. Market Snapshot
                      2.2. Segment Snapshot
                          2.2.1. Modality
                          2.2.2. Service
                          2.2.3. Specialist
                      2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                      3.1. Market Lineage Outlook
                          3.1.1. Parent market outlook
                      3.2. Market Segmentation
                      3.3. Market Dynamics
                          3.3.1. Market Driver Analysis
                              3.3.1.1. Increasing prevalence of target diseases
                              3.3.1.2. Preference to minimally invasive procedures
                          3.3.2. Market Restraint Analysis
                              3.3.2.1. High risk option for severe cases
                              3.3.2.2. Lack of technical training for the MIS procedure
                          3.3.3. Industry Opportunity Analysis
                              3.3.3.1. Approval of endovascular procedures in office-based labs
                              3.3.3.2. Flexibility for physicians to convert to OBLs
                      3.4. Regulatory Framework & Reimbursement Scenario
                          3.4.1. Regulatory Framework
                          3.4.2. Reimbursement Scenario
                      3.5. Industry Analysis Tools
                          3.5.1. Porter's Five Forces Analysis
                          3.5.2. PESTLE Analysis
Chapter 4. U.S. Office-Based Labs Market: Modality Analysis
                      4.1. U.S. Office-based Labs (OBLs): Modality Market Share Analysis, 2023 & 2030
                      4.2. Segment Dashboard
                      4.3. U.S. Office-based Labs (OBLs) Market, by Modality, 2018 - 2030
                      4.4. Market Size and Forecasts and Trend Analysis, 2018 - 2030 for the Modality
                          4.4.1. Single Specialty Labs
                              4.4.1.1. Single specialty labs market, 2018 - 2030 (USD Million)
                          4.4.2. Multi-Specialty Labs
                              4.4.2.1. Multi-specialty labs market, 2018 - 2030 (USD Million)
                          4.4.3. Hybrid Labs
                              4.4.3.1. Hybrid labs market, 2018 - 2030 (USD Million)
Chapter 5. U.S. Office-Based Labs Market: Service Analysis
                      5.1. U.S. Office-based Labs (OBLs): Service Market Share Analysis, 2023 & 2030
                      5.2. Segment Dashboard
                      5.3. U.S. Office-based Labs (OBLs) Market, by Modality, 2018 - 2030
                      5.4. Market Size and Forecasts and Trend Analysis, 2018 - 2030 for the Service
                          5.4.1. Peripheral Vascular Intervention
                              5.4.1.1. Peripheral vascular intervention market, 2018 - 2030 (USD Million)
                          5.4.2. Cardiac
                              5.4.2.1. Cardiac market, 2018 - 2030 (USD Million)
                          5.4.3. Interventional Radiology
                              5.4.3.1. Interventional radiology market, 2018 - 2030 (USD Million)
                          5.4.4. Venous
                              5.4.4.1. Venous market, 2018 - 2030 (USD Million)
                          5.4.5. Endovascular Interventions
                              5.4.5.1. Endovascular interventions market, 2018 - 2030 (USD Million)
                          5.4.6. Others
                              5.4.6.1. Others market, 2018 - 2030 (USD Million)
Chapter 6. U.S. Office-Based Labs Market: Specialist Analysis
                      6.1. U.S. Office-based Labs (OBLs): Specialist Market Share Analysis, 2023 & 2030
                      6.2. Segment Dashboard
                      6.3. U.S. Office-based Labs (OBLs) Market, by Modality, 2018 - 2030
                      6.4. Market Size and Forecasts and Trend Analysis, 2018 - 2030 for the Specialist
                          6.4.1. Vascular Surgeons
                              6.4.1.1. Vascular surgeons market, 2018 - 2030 (USD Million)
                          6.4.2. Interventional Cardiologists
                              6.4.2.1. Interventional cardiologists market, 2018 - 2030 (USD Million)
                          6.4.3. Interventional Radiologists
                              6.4.3.1. Interventional radiologists market, 2018 - 2030 (USD Million)
                          6.4.4. Other Specialists
                              6.4.4.1. Other specialists market, 2018 - 2030 (USD Million)
Chapter 7. U.S. Office-Based Labs Market: Regional Analysis
                      7.1. U.S. Office-Based Labs (OBLs) Market, 2018 - 2030 (USD Million)
                      7.2. U.S Office-Based Labs (OBLs) Market: Top 5 States
                          7.2.1. Penetration Analysis: Top 5 states 2022
                      7.3. Pricing Analysis
                          7.3.1. Average cost of major procedures performed in office-based labs
                          7.3.2. Average cost of major devices used in office-based labs
                          7.3.3. Average cost of setting up an office-based labs
Chapter 8. Competitive Analysis
                      8.1. Company Profiles
                          8.1.1. Suppliers
                              8.1.1.1. Koninklijke Philips N.V
                                  8.1.1.1.1. Overview
                                  8.1.1.1.2. Financial Performance
                                  8.1.1.1.3. Product Benchmarking
                                  8.1.1.1.4. Strategic Initiatives
                              8.1.1.2. GE Healthcare
                                  8.1.1.2.1. Overview
                                  8.1.1.2.2. Financial Performance
                                  8.1.1.2.3. Product Benchmarking
                                  8.1.1.2.4. Strategic Initiatives
                              8.1.1.3. Siemens Healthineers AG
                                  8.1.1.3.1. Overview
                                  8.1.1.3.2. Financial Performance
                                  8.1.1.3.3. Product Benchmarking
                                  8.1.1.3.4. Strategic Initiatives
                              8.1.1.4. Medtronic PLC
                                  8.1.1.4.1. Overview
                                  8.1.1.4.2. Financial Performance
                                  8.1.1.4.3. Product Benchmarking
                                  8.1.1.4.4. Strategic Initiatives
                              8.1.1.5. Boston Scientific Corporation
                                  8.1.1.5.1. Overview
                                  8.1.1.5.2. Financial Performance
                                  8.1.1.5.3. Product Benchmarking
                                  8.1.1.5.4. Strategic Initiatives
                              8.1.1.6. Abbott
                                  8.1.1.6.1. Overview
                                  8.1.1.6.2. Financial Performance
                                  8.1.1.6.3. Product Benchmarking
                                  8.1.1.6.4. Strategic Initiatives
                              8.1.1.7. Cardiovascular Systems, Inc.
                                  8.1.1.7.1. Overview
                                  8.1.1.7.2. Financial Performance
                                  8.1.1.7.3. Product Benchmarking
                                  8.1.1.7.4. Strategic Initiatives
                          8.1.2. Service Providers
                              8.1.2.1. Envision Healthcare Corporation
                                  8.1.2.1.1. Overview
                                  8.1.2.1.2. Financial Performance
                                  8.1.2.1.3. Service Benchmarking
                                  8.1.2.1.4. Strategic Initiatives
                              8.1.2.2. Surgical Care Affiliates (SCA)
                                  8.1.2.2.1. Overview
                                  8.1.2.2.2. Financial Performance
                                  8.1.2.2.3. Service Benchmarking
                                  8.1.2.2.4. Strategic Initiatives
                              8.1.2.3. Fresenius Medical Car
                                  8.1.2.3.1. Overview
                                  8.1.2.3.2. Financial Performance
                                  8.1.2.3.3. Service Benchmarking
                                  8.1.2.3.4. Strategic Initiatives
                              8.1.2.4. Cardiovascular Coalition
                                  8.1.2.4.1. Overview
                                  8.1.2.4.2. Financial Performance
                                  8.1.2.4.3. Service Benchmarking
                                  8.1.2.4.4. Strategic Initiatives
                              8.1.2.5. Surgery Partners
                                  8.1.2.5.1. Overview
                                  8.1.2.5.2. Financial Performance
                                  8.1.2.5.3. Service Benchmarking
                                  8.1.2.5.4. Strategic Initiatives
                              8.1.2.6. TH Medical
                                  8.1.2.6.1. Overview
                                  8.1.2.6.2. Financial Performance
                                  8.1.2.6.3. Service Benchmarking
                                  8.1.2.6.4. Strategic Initiatives
                      8.2. Company Categorization: Suppliers
                      8.3. Company Categorization: Service Providers
                      8.4. Company Market Position Analysis: Suppliers
                      8.5. Company Market Position Analysis: Service Providers
                      8.6. Company Market Position Analysis: Imaging Devices Manufacturer
                      8.7. Company Market Position Analysis: Vascular Intervention Devices
                      8.8. Strategy Mapping
Chapter 9. KOL Comments & Recommendations

List of Table s

Table 1. List of Secondary Sources
Table 2. List of Abbreviation
Table 3. Procedure codes and physician reimbursement, 2022
Table 4. Shifting trends from the inpatient facility to the outpatient facility
Table 5. U.S. Office-Based Labs Market, by Modality, 2018 - 2030 (USD Million)
Table 6. U.S. Office-Based Labs Market, by Services, 2018 - 2030 (USD Million)
Table 7. U.S. Office-Based Labs Market, by Specialists, 2018 - 2030 (USD Million)

List of Figures

Fig 1. Market research process
Fig 2. Information procurement
Fig 3. Primary research pattern
Fig 4. Market research approaches
Fig 5. Value chain-based sizing & forecasting
Fig 6. Market formulation & validation
Fig 7. U.S. office-based labs market segmentation
Fig 8. Market snapshot, 2023
Fig 9. Segment snapshot
Fig 10. Competitive landscape snapshot
Fig 11. Market trends & outlook
Fig 12. Market driver relevance analysis (current & future impact)
Fig 13. Market restraint relevance analysis (current & future impact)
Fig 14. PESTLE analysis
Fig 15. Porter’s five forces analysis
Fig 16. U.S. Office-Based Labs (OBLs) market: Modality outlook and key takeaways
Fig 17. U.S. Office-Based Labs (OBLs) market: Modality movement analysis
Fig 18. Single specialty labs market revenue, 2018 - 2030 (USD Million)
Fig 19. Multi-specialty labs market revenue, 2018 - 2030 (USD Million)
Fig 20. Hybrid labs media market revenue, 2018 - 2030 (USD Million)
Fig 21. U.S. Office-Based Labs (OBLs) market: Service outlook and key takeaways
Fig 22. U.S. Office-Based Labs (OBLs) market: Service movement analysis
Fig 23. Peripheral vascular intervention market revenue, 2018 - 2030 (USD Million)
Fig 24. Cardiac market revenue, 2018 - 2030 (USD Million)
Fig 25. Interventional radiology market revenue, 2018 - 2030 (USD Million)
Fig 26. Venous market revenue, 2018 - 2030 (USD Million)
Fig 27. Endovascular interventions market revenue, 2018 - 2030 (USD Million)
Fig 28. Other services market revenue, 2018 - 2030 (USD Million)
Fig 29. U.S. Office-Based Labs (OBLs) market: Specialists outlook and key takeaways
Fig 30. U.S. Office-Based Labs (OBLs) market: Specialists movement analysis
Fig 31. Vascular surgeons market revenue, 2018 - 2030 (USD Million)
Fig 32. Interventional cardiologists market revenue, 2018 - 2030 (USD Million)
Fig 33. Interventional radiologists market revenue, 2018 - 2030 (USD Million)
Fig 34. Other specialists market revenue, 2018 - 2030 (USD Million)
Fig 35. Penetration analysis: Top 5 states 2022
Fig 36. Company competition categorization: Suppliers
Fig 37. Company competition categorization: Service providers
Fig 38. Company market position analysis: Suppliers
Fig 39. Company market position analysis (Imaging devices manufacturer)
Fig 40. Company market position analysis (Vascular intervention devices)
Fig 41. Company market position analysis: Service providers